secwatch.observer — SEC 8-K summary
======================================

Issuer:     Adagio Medical Holdings, Inc. (ADGM)
CIK:        0002006986
Form:       8-K
Filed at:   2025-12-11T23:59:59+00:00
Accession:  0001104659-25-120352
Event type: leadership
Sentiment:  neutral
Materiality: 0.50
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Adagio Medical expands board to seven, appoints former Medtronic EVP Sean Salmon
--------------------------------------------------------------------------------

- Board increased from six to seven directors; Salmon appointed Class II director, term expiring at 2026 annual meeting.
- Salmon served as Medtronic EVP and President of Cardiovascular Portfolio from Jan 2021 to Sep 2025.
- Appointed to Audit and Compensation Committees; will receive standard non-employee director compensation.
- Company entered into standard indemnification agreement with Salmon.
- No arrangements or material transactions with any other person in connection with appointment.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/2006986/000110465925120352/0001104659-25-120352-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/2006986/000110465925120352/tm2533309d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-25-120352

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer